”Current and future use of “dried blood spot” analyses in clinical chemistry”;
S. Lehmann, C. Delaby, J. Vialaret, J. Ducos and C. Hirtz; Clin Chem Lab Med 2013 ; 51(10) : 1897–1909
Newsroom
- Capitainer’s qDBS dried blood spot system for home self-sampling proves 97% effective for clinical mass-testing of Covid-19 vaccine efficacy
- Capitainer attracts former Karolinska University Hospital Laboratory Unit Manager Mikael Ström as Business Development Manager
- Sweden’s Västerbotten Region first to introduce home sampling for COVID-19 antibodies together with Capitainer
- New study shows that the new Capitainer PEth system tailored for analysis of PEth enables accurate and court-admissible monitoring of alcohol abuse
- Capitainer’s qDBS dried blood spot system for home sample collection employed in a nation-wide COVID-19 study in the US
- Capitainer raises further SEK31 million to meet anticipated demand for qDBS dried blood spot sampling system as COVID-19 vaccine programs are rolled out
- Capitainer awarded ISO 13485:2016 as interest grows in qDBS testing for COVID-19 and other challenging applications
